Informed Consent?

Novartis moves to stop execution drug from reaching the U.S.

I just wonder how the clinical trials worked for a drug that is used for such a purpose….

Novartis and its Sandoz unit, maker of a generic version of an anesthetic used in lethal injections in the United States, have taken steps to try to stop the drug ending up in the United States. Click here to read the Reuters article.

Or as Pfizer’s Craig Lipset asked on Linkedin:

Time to invest in firing squads?


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: